Latest News From Lumira Ventures

Bright Angel Therapeutics Announces New Funding to Advance Therapies for Invasive Fungal Infections

Jennifer Schram Bright Angel Therapeutics, Lumira News, Portfolio News, Press Release

TORONTO – Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal drugs, today announced an extension to their seed financing round, adding funding that will enable continued advancement of their lead program targeting invasive and drug-resistant fungal infections. …